Alembic Pharmaceuticals gets FDA nod for diclofenac
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.
AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million
Removing gender inequalities on womenās HIV risks can help end the AIDS pandemic, according to UNAIDS.
A breakthrough new bandage design utilizing microgels can help heal wounds faster.
The FDA is probing a drug, Prolia, used for the treatment of advanced kidney disease after initial investigations showed āa substantial risk with.
An experimental cholesterol drug reduced LDL cholesterol by 70% in mouse models.
Baxter International has pulled the plug on its hospital bed systems in a recall termed by the FDA as āmost seriousā as the.
Biovac, a South Africa-based biotechnology company, has signed a technology transfer agreement with a South Korean institute to make an oral cholera vaccine.
Forty million children in 2021 have missed their measles vaccination since the beginning of the Covid-19 outbreak, which disrupted the dose schedules, according.
Sugar substitutes can kill off antibiotic-resistant bacteria that cause pneumonia and sepsis